A phase I/II randomized controlled trial PedVacc @ was conducted to determine the safety and immunogenicity of a single , low dose of MVA.HIVA vaccine delivered intramuscularly to healthy @-week-old infants born to HIV-@-positive mothers in Nairobi , Kenya .